Abstract
The first vaccine was discovered for the prevention of smallpox in 1796, from where the vaccine for rabies followed in 1885. Vaccines are used to improve the immunity of an infected individual but have a very low immunogenicity and no effective responses have been found for severe infections and cancer. Adjuvants were developed to circumvent this problem by increasing the effect of the vaccine by steering the immune system into a desired direction, thus creating an immune response that includes both innate and adaptive immunity. Natural products have been used throughout the centuries for many illnesses such as colds and flu but also for many serious conditions such as liver diseases and cancer. These medicines are known to produce their effects through an immunomodulatory response. Numerous benefits have been attributed for the use of medicinal plants for immunomodulation instead of synthetically produced immunotherapeutics. Many natural products with known immunostimulatory properties have the potential to target certain responses required for the effective control of infections, chronic diseases and cancer. By combining vaccines with an adjuvant, it may be possible to increase the low immunogenicity and the overall effectiveness of the vaccine by providing a stable, targeted and prolonged immune response, needed for the effective treatment and prevention of cancer and infectious diseases. Natural products have the potential in providing the properties for the making of an effective vaccine adjuvant.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alamgir M, Uddin SJ (2010) Recent advances on the ethnomedicinal plants as immunomodulatory agents. In: Ethnomedicine: a source of complementary therapeutics. Debprasad Chattopadhyay. Research Signpost, Trivandrum, pp 227–244
Aldahlawi AM (2016) Modulation of dendritic cell immune functions by plant components. J Microsc Ultrastruct 4(2):55–62
Amorij JP, Saluja V, Petersen AH et al (2007) Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray- freezing drying induces systemic, mucosal humoral as well as cell- mediated immune responses in BALB/c mice. Vaccine 25:8707–8717
Atmar RL, Keitel WA, Patel SM (2006) Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza a/H9N2 vaccine preparations. Clin Infect Dis 43(9):1135–1142
Aucouturier J, Dupuis L, Deville S et al (2002) Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines. Expert Rev Vaccines 1(1):111–118
Awate S, Babiuk LA, Mutwiri G (2013) Mechanisms of action of adjuvants. Front Immunol 4:114
Banday AH, Jeelani S, Hruby VJ (2015) Cancer vaccine adjuvants- recent clinical progress and future prospects. Immunopharmacol Immunotoxicol 37(1):1–11
Bejon P, Lusingu J, Olotu A et al (2008) Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. N Engl J Med 359:2521–2532. https://doi.org/10.1056/NEJMoa0807381
Ben-Yadidia T, Arnon R (2005) Towards an epitope-based human vaccine for influenza. Hum Vaccines 1(3):95–101
Bernd A, Ramirez-Bosca A, Huber J et al (1995) In vitro studies on the immunomodulating effects of Polypodium leucotomos extract on human leukocyte fractions. Arzneimittelforschung 45:901–904
Bode C, Zhao G, Steinhagen F et al (2011) CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10(4):499–511
Bovier PA (2008) Epaxal: a virosomal vaccine to prevent hepatitis a infection. Expert Rev Vaccines 7(8):1141–1150. https://doi.org/10.1586/14760584.7.8.1141
Brewbooks (2015) Taxus brevifolia. https://commons.wikimedia.org/w/index.php?search=Taxus+brevifolia+&title=Special:Search&profile=default&fulltext=1&searchToken=e1ht9f6ad6l6rthlx7imjs0r7#/media/File:Taxus_brevifolia_(Pacific_yew)_-_Flickr_-_brewbooks_(1).jpg. Accessed 20 Nov 2017
Bauer C, Duewell P, Mayer C et al (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59(9):1192–1199
Calabro S, Tortoli M, Baudner BC et al (2011) Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29:1812–1823
Chen L, Yu J (2016) Modulation of Toll-like receptor signaling in innate immunity by natural products. Int Immunopharmacol 37:65–70
Chen Z, Lu J, Srinivasan N et al (2009) Polysaccharide protein complex from Lycium barbarum L. is a novel stimulus of dendritic cell immunogenicity. J Immunol 182:3503–3509
Cleland JL, Kensil CR, Lim A et al (1996) Isomerization and formulation stability of the vaccine adjuvant QS-21. J Pharm Sci 85(1):22–28
Cooper PD, Turner R, McGovern J (1991) Algammulin (g inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice. Immunol Lett 27:131–134
Cox JC, Coulter AR (1997) Adjuvants-a classification and review of their modes of action. Vaccine 15:248–256
Coyle AJ, Gutierrez-Ramos JC (2001) The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol 2:203–209
Culbert (2013) Quillaja saponaria. https://commons.wikimedia.org/w/index.php?search=Quillaja+saponaria+&title=Special:Search&profile=default&fulltext=1&searchToken=31ew28hc7fwxyjz9pwl7km8ia#/media/File:Quillaja_saponaria_(8682583634).jpg. Accessed 20 Nov 2017
Dalgial (2009). Plantago asiatica. https://commons.wikimedia.org/w/index.php?search=Plantago+asiatica+&title=Special:Search&profile=default&fulltext=1&searchToken=554b9v2m6kzc1u5m4efxn2s6g#/media/File:Plantago_asiatica_2.JPG. Accessed 20 Nov 2017
Danny S (2011) Lycium barbarum. https://commons.wikimedia.org/wiki/File:Lycium_barbarum-46.JPG. Accessed 22 Nov 2017
De Gregorio E, Caproni E, Ulmer JB (2013) Vaccine adjuvants: mode of action. Front Immunol 4:214
De Smet PA (1997) The role of plant-derived drugs and herbal medicines in healthcare. Drugs 54:801–840
De Veer M, Kemp J, Chatelier J et al (2010) The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminium- based adjuvant. Vaccine 28(40):66597–66602
Di Pasquale A, Preiss S, Da Silva FT et al (2015) Vaccine adjuvants: from 1920 to 2015 and beyond. Vaccine 3(2):320–343
Didierlaurent AM, Morel S, Lockman L et al (2009) AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J Immunol 183:6186–6197
Doronenko S (2011) Achyranthes bidentata. https://commons.wikimedia.org/w/index.php?search=Achyranthes+bidentata+&title=Special:Search&profile=default&fulltext=1&searchToken=62vcy2al8tm5uwtqjm4mt5kyi#/media/File:Achyranthes_bidentata_flower.jpg. Accessed 20 Nov 2017
Durando P, Fenoglio D, Boschini A et al (2008) Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and—seronegative adults. Clin Vaccine Immunol 15(2):253–259
Didierlaurent AM, Collignon C, Bourguignon P et al (2014) Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells. J Immunol 193(4):1920–1930
El-Ashmawy NE, El-Zamarany EA, Salem ML et al (2015) In vitro and in vivo studies of the immunomodulatory effect of Echinacea purpurea on dendritic cells. J Genet Eng Biotechnol 13(2):185–192
Fernandez-Tejada A, Tan DS, Gin DY (2016) Development of improved vaccine adjuvants based on the saponin natural product QS-21 through chemical synthesis. Acc Chem Res 49(9):1742–1756
Fisch F (2006) Inulin structure. https://commons.wikimedia.org/w/index.php?search=inulin&title=Special:Search&profile=default&fulltext=1&searchToken=6ye14f1dvnhrud46eclkv5toz#/media/File:Inulin_strukturformel.png. Accessed 22 Nov 2017
Fox CB, Haensler J (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Rev Vaccines 12(7):747–758. https://doi.org/10.1586/14760584.2013.811188
Fraser CK, Diener KR, Brown MP et al (2007) Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 6:559–578
Frokiaer H, Hennigsen SB, Metzdorff G et al (2012) Astragalus root and elderberry fruit extracts enhance the IFN-beta stimulatory effects of Lactobacillus acidophilus in murine-derived dendritic cells. PLoS One 7:47878
Garcon N, Van Mechelen M (2011) Recent clinical experience with vaccines using MPL- and QS-21 containing adjuvant systems. Expert Rev Vaccines 10:471–486
Garçon N, Chomez P, Van Mechelen M (2007) GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives. Expert Rev Vaccines 6(5):723–739. https://doi.org/10.1586/14760584.6.5.723
Garçon N, Segal L, Tavares F, van Mechelen M (2011) The safety evaluation of adjuvants during vaccine development: the AS04 experience. Vaccine 29:4453–4459
Garlapati S (2012) Do we know the Th1/Th2/Th17 determinants of vaccine response? Expert Rev Vaccine 11:1307–1310
Ghendon Y, Markushin S, Vasiliev Y et al (2009) Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally. J Med Virol 81(3):494–506
Ghochikyan A, Pichigin A, Bagaev A (2014) Targeting TLR-4 with a novel pharmaceutical grade plant derived agonist, Immunomax, as a therapeutic strategy for metastatic breast cancer. J Transl Med 12:322
Goto N, Akama K (1982) Histopathological studies of reactions in mice injected with aluminum-adsorbed tetanus toxoid. Microbiol Immunol 26:1121–1132
Guy B (2007) The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5:505–517
Halmuthur MSK, Irfan H (2012) Pattern recognition receptors based immune adjuvants: their role and importance in vaccine design. In: Medicinal Chemistry and Drug Design. https://doi.org/10.5772/38841
Hanson MC et al (2015) Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants. J Clin Invest 125(6):2352–2546
Harikrishnan R, Balasundaram C, Heo M (2011) Impact of plant products on innate and adaptive immune system of cultured finfish and shellfish. Aquaculture 317:1–15
Herbert WJ (1968) The mode of action of mineral-oil emulsion adjuvants on antibody production in mice. Immunology 14:301–318
Hoebe K, Janssen E, Beutler B (2004) The interface between innate and adaptive immunity. Nat Immunol 5:971–974
Honda-Okubo Y, Saade F, Petrovsky N (2012) Advax™, a polysaccharide derived from delta inulin, provides improved influenza vaccine protection through broad based enhancement of adaptive immune responses. Vaccine 30(36):5373–5381
Huang DF, Tang YF, Nie SP et al (2009) Effect of phenylethanoid glycosides and polysaccharides from the seed of Plantago asiatica L. on the maturation of murine bone marrow-derived dendritic cells. Eur J Pharmacol 620:105–111
Ilyinskii PO et al (2014) Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 32(24):2882–2895. https://doi.org/10.1016/j.vaccine.2014.02.027
Jakob T, Walker PS, Krieg AM et al (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161(6):3042–3049
Jing XN, Qiu B, Wang YG et al (2014) In vitro anti-tumor effect of human dendritic cells vaccine induced by Astragalus polysacharin: an experimental study. Zhongguo Zhong Xi Yi Jie He Za Zhi 34:1103–1107
Kasturi SP et al (2011) Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470:543–547. https://doi.org/10.1038/nature09737
Kaufmann SHE (2010) Novel tuberculosis vaccine strategies based on understanding the immune response. J Intern Med 267(4):337–353
Keisotyo (2003) Uncaria rhynchophylla. https://commons.wikimedia.org/w/index.php?search=Uncaria+rhynchophylla+&title=Special:Search&profile=default&fulltext=1&searchToken=4xp90obgqj2eqv3snn4jqq41q#/media/File:Uncaria_rhynchophylla_kagikzr01.jpg. Accessed 21 Nov 2017
Kester KE, Cummings JF, Ofori-Anyinam O et al (2009) Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 200(3):337–346. https://doi.org/10.1086/600120
Khajuria A, Gupta A, Malik F et al (2007) A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg. Vaccine 25(23):4586–4594. https://doi.org/10.1016/j.vaccine.2007.03.051
Kkarageorgos (2010). Pleurotus ferulae. https://commons.wikimedia.org/w/index.php?search=Pleurotus+ferulae+&title=Special:Search&profile=default&fulltext=1&searchToken=51lm5u4ef6ls53ogmx18amr9a#/media/File:Pleurotus_eryngii_var._ferulae.jpg. Accessed 21 Nov 2017
Klinman DM (2006) Adjuvant activity of CpG oligodeoxynucleotides. Int Rev Immunol 25(3–4):135–154
Kreuter J (1988) Possibilities of using nanoparticles as carriers for drugs and vaccines. J Microencapsul 5:115–127
Kumar HM, Singh PP, Qazi NA (2010) Development of novel lapidated analogs of picroside as vaccine adjuvants: acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice. Vaccine 28(52):8327–8337
Kurokawa K, Ishii T, An WW et al (2011) A heat stable extract from mucuna stimulates the differentiation of bone marrow cells into dendritic cells and induces apoptosis in cancer cells. Nutr Cancer 63:100–108
Lambrecht BN, Kool M, Willart MA (2009) Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 21:23–29
Lee S, Nguyen MT (2015) Recent advances of vaccine adjuvants for infectious diseases. Immune Netw 15(2):551–557
Leroux-Roels G, Leroux-Roels I, Clement F et al (2014) Evaluation of the immune response to RTS,S/AS01 and RTS, S/AS02 adjuvanted vaccines: randomized, double-blind study in malaria-naïve adults. Hum Vaccines Immunother 10(8):2211–2219. https://doi.org/10.4161/hv.29375
Lestat (2008) Papaver somniferum. https://commons.wikimedia.org/w/index.php?search=Papaver+somniferum&title=Special:Search&profile=default&fulltext=1&searchToken=32ym1epm52yzi0wjt5sx3za89#/media/File:Papaver_somniferum_01.JPG. Accessed 20 Nov 2017
Leucotomos (2014) Polypodium leucotomos. https://commons.wikimedia.org/wiki/File:Polypodium_Leucotomos.jpg. Accessed 20 Nov 2017
Levast B, Awate S, Babiuk L et al (2014) Vaccine potentiation by combination adjuvants. Vaccine 2(2):297–322
Li J, Wang X, Wang W et al (2015) Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. Vaccine 33:1923–1933
Lim YT (2015) Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease. Clin Exp Vaccine Res 4(1):54–58
Luckheeram RV, Zhou R, Verma AD et al (2012) CD4+ T cells: differentiation and functions. Clin Dev Immunol 2012:925135. https://doi.org/10.1155/2012/925135
Marrack P, McKee AS, Munks MW (2009) Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 9(4):287–293
Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265
Massa S, Franconi R (2012) Plant genes and plant proteins as adjuvants in cancer vaccination. Med Aromat Plant Sci Biotechnol 6(2):1–9
McKenziea FC, Apostolopoulosa V, Leesa C et al (1998) Oxidised mannan antigen conjugates preferentially stimulate T1 type immune responses. Vet Immunol Immunopathol 63(1–2):185–190
Mohan T, Verma P, Rao DN (2013) Novel adjuvants and delivery vehicles for vaccine development: a road ahead. Indian J Med Res 138(5):779–795
Moore A, McCarthy L, Mills KGH (1999) The adjuvant combination monophosphoryl lipid a and QS21 switches T cell responses induced with a soluble recombinant HIV protein from Th2 to Th1. Vaccine 17:2517–2527
Morel S, Didierlaurent A, Bourguignon P et al (2011) Adjuvant system AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 29:2461–2473
Moser M, Leo O (2010) Key concepts in immunology. Vaccine 28(Suppl 3):C2–C13. https://doi.org/10.1016/j.vaccine.2010.07.022
Moser C, Müller M, Kaeser MD, Weydemann U et al (2013) Influenza virosomes as vaccine adjuvant and carrier system. Expert Rev Vaccines 12(7):779–791. https://doi.org/10.1586/14760584.2013.811195
Moyer TJ, Zmolek AC, Irvine DJ (2016) Beyond antigens and adjuvants: formulating future vaccines. J Clin Invest 126(3):799–808
Nakagawa R, Motoki K, Ueno H, Iijima R, Nakamura H, Kobavashi E, Shimosaka A, Koezuka Y (1998) Treatment of hepatic metastasis of the colon26 adenocarcinoma with an alpha-galactosylceramide, KRN7000. Cancer Res 58(6):1202–1207
Nakagawa R, Serizawa I, Motoki K, Sato M, Ueno H, Iijima R, Nakamura H, Shimosaka A, Koezuka Y (2000) Antitumor activity of alpha-galactosylceramide, KRN7000, in mice with the melanoma B16 hepatic metastasis and immunohistological study of tumor infiltrating cells. Oncol Res 12(2):51–58
Nakaya K, Nabata Y, Ichiyanagi T (2012) Stimulation of dendritic cell maturation and induction of apoptosis in leukemia cells by a heat-stable extract from azuki bean (Vigna angularis), a promising immunopotentiating food and dietary supplement for cancer prevention. Asian Pac J Cancer Prev 13:607–611
Ng H, Fernando GJP, Depelsenaire ACI, Kendall MAF (2016) Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing. Sci Rep 6:29368
NI74 (2007) Polyporus umbellatus. https://commons.wikimedia.org/w/index.php?search=Polyporus+umbellatus+&title=Special:Search&profile=default&fulltext=1&searchToken=671mjwu2t19yujilkkx69ive7#/media/File:Polyporus_umbellatus.jpg. Accessed 21 Nov 2017
Nicholls EF, Madera L, Hancock REW (2010) Immunomodulators as adjuvants for vaccines and antimicrobial therapy. Ann N Y Acad Sci 1213:46–61
Ohnmacht C, Pullner A, King SB et al (2009) Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 206(3):549–559
Okamoto M, Oh EG, Oshikawa T et al (2004) Toll-like receptor 4 mediates the antitumor host response induced by a 55-kilodalton protein isolated from Aeginetia indica L., a parasitic plant. Clin Diagn Lab Immunol 11:483–495
Pashine A, Valiante NM, Ulmer JB (2005) Targeting the innate immune response with improved vaccine adjuvants. Nat Med 11:63–68
Petrovsky N (2008) Freeing vaccine adjuvants from dangerous immunological dogma. Expert Rev Vaccines 7:7–10
Petrovsky N (2013) Vaccine adjuvants: in search of new paradigms. Expert Rev Vaccines 12(7):723–726
Petrovsky N (2015) Comparative safety of vaccines adjuvants: a summary of current evidence and future needs. Drug Saf 38(11):1059–1074
Podda A, Del Giudice G, O’Hagan D (2006) MF59: a safe and potent adjuvant for human use. Immunopotent Modern Vaccines:149–159. https://doi.org/10.1016/B978-012088403-2/50010-1
Poland GA, Jacobson RM (2001) The prevention of Lyme disease with vaccine. Vaccine 21(19):2303–2308
Puri A, Saxena RP, Sumati Guru PY (1992) Immunostimulant activity of Picroliv, the iridoid glycoside fraction of Picrorhiza kurroa, and its protective action against Leishmania donovani infection in hamsters. Planta Med 58(6):528–532
Ragupathi G, Gardner JR, Livingston PO et al (2011) Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Rev Vaccines 10(4):463–470
Rappuoli R, De Gregorio E (2016) Editorial overview: vaccines: novel technologies for vaccine development. Curr Opin Immunol 41:v–vii. https://doi.org/10.1016/j.coi.2016.07.001
Rasbak (2005) Lemna minor. https://commons.wikimedia.org/wiki/Lemna_minor#/media/File:Klein_kroos_Lemna_minor.jpg. Accessed 21 Nov 2017
Reed SG, Hsu FC, Carter D (2016) The science of vaccine adjuvants: advances in TLR4 ligand adjuvants. Curr Opin Immunol 41:85–90
Rey-Ladino J, Ross AG, Cripps AW et al (2011) Natural products and the search for novel vaccine adjuvants. Vaccine 29(38):6464–6471
Riese P, Schulze K, Ebensen T et al (2013) Vaccine adjuvants: key tools for innovative vaccine design. Curr Top Med Chem 13(20):2560–2580
Rivera E, Ekholm PF, Inganas M et al (2005) The RB1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23:5411–5419
Santini SM, Belardelli F (2003) Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines. Stem Cells 21:495–505
Saul A, Lord R, Jones GL et al (1992) Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J Immunol 148:208–211
Schleiss MR, Yeon-Choi K, Anderson J et al (2014) Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine 32(23):2756–2762
Shakya AK, Nandakumar SK (2012) Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases. J R Soc Interface 10:1–16
Shao P, Zhao LH, Zhi C et al (2006) Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharides. Int Immunopharmacol 6:1161–1166
Sharp FA, Ruane D, Claass B et al (2009) Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome. Proc Natl Acad Sci U S A 106(3):870–875
Sheu SC, Lai MH (2012) Composition analysis and immuno-modulatory effect of okra (Abelmoschus esculentus L.) extract. Food Chem 134:1906–1911
Shi CE, Xiong Z, Chittepu P et al (2012) Discovery of imidazoquinolines with toll-like receptor 7/8 independent cytokine induction. ACS Med Chem Lett 3(6):501–504
Singh M, O’Hagan D (1999) Advances in vaccine adjuvants. Nature 17:1075–1081
Singh M, O’Hagan DT (2003) Recent advances in veterinary vaccine adjuvants. Int J Parasitol 33:469–478
Siskind GW, Benacerraf B (1969) Cell selection by antigen in the immune response. Adv Immunol 10:1–50
Sjolander A, Cox JC, Barr IG (1998) ISCOMS: an adjuvant with multiple functions. J Leukoc Biol 64:713–723
Steinhagen F, Kinjo T, Bode C et al (2011) TLR-based immune adjuvants. Vaccine 29(17):3341–3355
Stern AM, Markel H (2005) The history of vaccines and immunization: familiar patterns, new challenges. Health Aff 24(3):611–621
Summerfield A, McCullough KC (2009) Dendritic cells in innate and adaptive immune responses against influenza virus. Viruses 1(3):1022–1034
Szabo A, Gogolak P, Pazmandi K et al (2013) The two-component adjuvant IC31 boosts type I interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs. PLoS One 8(10):1–13
Thiel S, Gadjeva M (2009) Humoral pattern recognition molecules: Mannan binding lectin and Ficolins. In: Kishore U (ed) Target pattern recognition in innate immunity, Advances in Experimental Medicine and Biology, vol 633. Springer, New York, NY
Thompson BS, Chiton PM, Ward JR (2005) The low toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J Leukoc Biol 78(6):1273–1280
Turley CB, Rupp RE, Johnson C et al (2011) Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults. Vaccine 29(32):5145–5152
Vajdy M, Srivastava I, Polo J et al (2004) Mucosal adjuvants and delivery systems for protein, DNA- and RNA-based vaccines. Immunol Cell Biol 82:617–627
Vogel F, Hem SL (2004) Vaccines. In: Immunologic adjuvants. Saunders Elsevier, Philadelphia, PA, USA, pp 69–79
Waite DC, Jacobson EW, Ennis FA et al (2001) Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine 19:3957–3967
Wang D, Hu Y, Sun J et al (2005) Comparative study on adjuvanticity of compound Chinese herbal medicine ingredients. Vaccine 23:3704–3708
WHO (2018) World Health Organization. The power of vaccines: Still not fully utilized yet. http://www.who.int/publications/10-year-review/vaccines/en/. Accessed 21 Mar 2018
Zhao Y, Yang J, Shi J et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600
Zou Y, Meng W, Chen J et al (2011) Modulation of phenotypic and functional maturation of murine dendritic cells (DCs) by purified Achyranthes bidentata polysaccharide (ABP). Int Immunopharmacol 11:1103–1108
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
_-_Flickr_-_brewbooks_(1).jpg){kind=link}
.jpg){kind=link}
Cite this chapter
Reid, AM., Lall, N. (2019). Natural Products as Possible Vaccine Adjuvants for Infectious Diseases and Cancer. In: Joshee, N., Dhekney, S., Parajuli, P. (eds) Medicinal Plants. Springer, Cham. https://doi.org/10.1007/978-3-030-31269-5_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-31269-5_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31268-8
Online ISBN: 978-3-030-31269-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)